<DOC>
	<DOCNO>NCT01411813</DOCNO>
	<brief_summary>This study examine role anxiety food intake among patient AN measure caloric intake standardize , laboratory meal alprazolam versus placebo . Patients participate two test meal session , one receiving alprazolam one receiving placebo . Patients administer psychological measure anxiety , mood , eat behavior . Primary outcome include caloric intake laboratory test meal pre-meal anxiety level .</brief_summary>
	<brief_title>Alprazolam Eating Behavior Anorexia Nervosa</brief_title>
	<detailed_description>30 patient Anorexia Nervosa ( hospitalize NYSPI 4-Center acute weight restoration treatment ) recruit participate experiment . All subject screen admission provide inform consent prior participation . At time study procedure , participant medically stable weigh ≥ 80 % IBW . This minimum weight identify patient safety give test meal procedure . Subjects participate total two meal session BSU . Medical clearance determine 4-Center clinical staff prior meal session . Study participation prolong interfere patient 's treatment . The first test meal occur patient reach 80 % IBW . The second test meal occur within week first . The procedure identical two test session , base describe Sysko colleague ( 9 ) . On morning test meal , participant provide standardized breakfast ~300 kcal . They consume additional food liquid , water , prior test meal session approximately 4 hour later . Study medication administer 10:00 . Test meal conduct Biological Studies Unit ( BSU ) NYSPI . Participants escort BSU research staff . Participants complete questionnaire prior receive medication , prior test meal , test meal complete ( see Table ) . Participants present 83 fluid ounce cover opaque container straw table . Inside container approximately 1500 gram ( approximately 1560 kcal ) strawberry yogurt shake . Patients informed meal consist strawberry yogurt shake , informed amount provide container . Instructions test meal inform patient eat much shake would like , meal would serve lunch day . The participant alone room . For compliance safety , patient observe closed circuit video monitor meal . The patient instruct signal completion meal ring bell . During course meal , patient ask rate anxiety periodically . After test meal complete , staff member debrief participant address question concern . Medication Administration : Participants receive active medication ( alprazolam 0.75 mg ) one test day placebo , random order . Dose select base finding Evans et al ( 8 ) , demonstrate statistically significant increase caloric intake dos alprazolam 0.5 mg 0.75 mg . Medication administer 2 hour prior test meal , time estimate peak plasma concentration ( 8 ) .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>1 . DSMIVTR™ diagnosis anorexia nervosa ( restrict bingepurge subtype ) , without amenorrhea time inpatient admission . 2 . Older 18 3 . No acute medical condition 4 . Participation inpatient treatment 5 . Subjects must sign informed consent document indicate understand purpose procedure require study willing participate study . 1 . Psychotic bipolar I disorder 2 . Substance abuse dependence last 6 month 3 . Current Axis I disorder require psychotropic medication ( subject take stable dose psychiatric medication allow . ) 4 . Active suicidal intent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>